• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » E-Cigarettes vs Nicotine Replacement for Smoking Cessation

E-Cigarettes vs Nicotine Replacement for Smoking Cessation

June 10, 2020
Jason Mallo, DO
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Jason Mallo, DO. Dr. Mallo has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Hajek P et al, N Engl J Med 2019;380(7):629–637

E-cigarettes are increasingly popular, often touted as exposing users to fewer toxins than combustible cigarettes. Might they be useful for smoking cessation and abstinence? To answer this question, Hajek et al performed a multicenter randomized controlled trial comparing e-cigarettes to nicotine-replacement therapy (NRT) in adults seeking help to quit smoking.

Participants were recruited through a smoking cessation program in the United Kingdom. Of the 2045 screened, 886 participants (median age 41 years, 51.8% male, average of 15 cigarettes per day) were enrolled in the study based on not having a strong preference for e-cigarettes or NRT and not currently using either product. They were then randomized to receive either an e-cigarette or NRT, and asked not to use the non-assigned product.

Those in the e-cigarette group were given an e-cigarette and bottle of tobacco-flavored e-liquid containing 18 mg/mL of nicotine, and directed to purchase their own future e-liquid. Those in the NRT group were offered their preferred product; most participants chose the patch combined with the gum.

At baseline, 4 weeks, and 1 year, participants completed trial visits in which carbon monoxide levels (a proxy for combustible cigarette consumption) were checked. Most participants (78.8%) completed the 1-year follow-up. Dropouts were classified as not being abstinent. The primary outcome measured was sustained abstinence at 1 year. Secondary outcomes included reported treatment usage, perceptions of assigned products, and respiratory symptoms.

Abstinence rates were higher in the e-cigarette group at all time points. The e-cigarette group achieved a 1-year abstinence rate of 18.0%, compared with 9.9% in the NRT group (RR 1.83, CI 1.30–2.58). Among all participants who did not achieve abstinence, those in the ­e-cigarette group also had higher rates of reduced smoking (RR 1.75, CI 1.12–2.72). The authors speculated that ­e-cigarettes were more effective because they better alleviated tobacco withdrawal and allowed for greater tailoring of treatment dose.

There was a higher rate of product usage in the e-cigarette group than in the NRT group: 39.5% and 4.3% at the end of the 1-year study period, respectively. This difference was even greater among participants with 1 year of abstinence (80% vs 9%). E-cigarettes were rated higher than nicotine replacement in terms of providing satisfaction and reducing urges to smoke.

Interestingly, regarding respiratory symptoms, the e-cigarette group had less cough and phlegm than the NRT group, and both groups were similar regarding incidence of wheezing and shortness of breath.

CATR’s Take
Smoking cessation remains difficult, as demonstrated by the low success rate in this study regardless of the treatments rendered. E-cigarettes may be more efficacious than NRT for abstinence in those motivated to quit smoking. Still, given the risks associated with e-cigarettes—including vaping-associated illnesses, inhaling potentially toxic aerosols, and the possibility of burns from vaporizer devices—clinicians should use caution in recommending e-cigarettes as treatment. Clinicians should also be mindful of the CDC’s guidance, issued in February 2020, which states that patients choosing to use e-cigarettes for smoking cessation should completely switch from cigarettes to e-cigarettes and avoid an extended period of dual use. Further research is needed to compare e-cigarettes with other smoking cessation treatment modalities, including bupropion, varenicline, and behavioral treatments.
Addiction Treatment
KEYWORDS abstinence e-cigarettes research-update smoking-cessations tobacco-research
    Jason Mallo, DO

    How to Diagnose Borderline Personality Disorder

    More from this author
    www.thecarlatreport.com
    Issue Date: June 10, 2020
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Emerging Risks for Old Medications, CATR, May/June 2020
    Gabapentin for Alcohol Use Disorder, Redux
    Does Baclofen Titrated to High Doses Reduce Alcohol Use?
    Amphetamines and Topiramate for Cocaine Use Disorder
    E-Cigarettes vs Nicotine Replacement for Smoking Cessation
    Benzodiazepines: Old Medicines, New Concerns
    Muscle Relaxants: Sedatives Often Under the Radar
    SAMHSA Relaxes Regulations on Methadone and Buprenorphine During COVID-19 Emergency
    Gabapentin Misuse and Diversion
    The “Z-Drugs”: Safety Issues and Misuse Potential
    Note From the Editor-in-Chief
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.